0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sepsis and Septic Shock Treatment Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-32B7620
Home | Market Reports | Health| Health Conditions
Global Sepsis and Septic Shock Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Sepsis and Septic Shock Treatment Market Research Report 2024

Code: QYRE-Auto-32B7620
Report
June 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sepsis and Septic Shock Treatment Market Size

The global Sepsis and Septic Shock Treatment market was valued at US$ 3352.9 million in 2023 and is anticipated to reach US$ 4453.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.

Sepsis and Septic Shock Treatment Market

Sepsis and Septic Shock Treatment Market

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sepsis and Septic Shock Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis and Septic Shock Treatment.

Report Scope

The Sepsis and Septic Shock Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis and Septic Shock Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sepsis and Septic Shock Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sepsis and Septic Shock Treatment Market Report

Report Metric Details
Report Name Sepsis and Septic Shock Treatment Market
Accounted market size in 2023 US$ 3352.9 million
Forecasted market size in 2030 US$ 4453.9 million
CAGR 4.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Cephalosporin
  • Pencillin
  • Macrolides
  • Others
Segment by Application
  • Sepsis
  • Septic Shock
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Viatris, AbbVie, Merck & Co, Asahi Kasei, AtoxBio, INOTREM, Adrenomed, Endacea
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sepsis and Septic Shock Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sepsis and Septic Shock Treatment Market growing?

Ans: The Sepsis and Septic Shock Treatment Market witnessing a CAGR of 4.2% during the forecast period 2024-2030.

What is the Sepsis and Septic Shock Treatment Market size in 2030?

Ans: The Sepsis and Septic Shock Treatment Market size in 2030 will be US$ 4453.9 million.

Who are the main players in the Sepsis and Septic Shock Treatment Market report?

Ans: The main players in the Sepsis and Septic Shock Treatment Market are Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA, Viatris, AbbVie, Merck & Co, Asahi Kasei, AtoxBio, INOTREM, Adrenomed, Endacea

What are the Application segmentation covered in the Sepsis and Septic Shock Treatment Market report?

Ans: The Applications covered in the Sepsis and Septic Shock Treatment Market report are Sepsis, Septic Shock

What are the Type segmentation covered in the Sepsis and Septic Shock Treatment Market report?

Ans: The Types covered in the Sepsis and Septic Shock Treatment Market report are Cephalosporin, Pencillin, Macrolides, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cephalosporin
1.2.3 Pencillin
1.2.4 Macrolides
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sepsis and Septic Shock Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Sepsis
1.3.3 Septic Shock
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sepsis and Septic Shock Treatment Market Perspective (2019-2030)
2.2 Sepsis and Septic Shock Treatment Growth Trends by Region
2.2.1 Global Sepsis and Septic Shock Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sepsis and Septic Shock Treatment Historic Market Size by Region (2019-2024)
2.2.3 Sepsis and Septic Shock Treatment Forecasted Market Size by Region (2025-2030)
2.3 Sepsis and Septic Shock Treatment Market Dynamics
2.3.1 Sepsis and Septic Shock Treatment Industry Trends
2.3.2 Sepsis and Septic Shock Treatment Market Drivers
2.3.3 Sepsis and Septic Shock Treatment Market Challenges
2.3.4 Sepsis and Septic Shock Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis and Septic Shock Treatment Players by Revenue
3.1.1 Global Top Sepsis and Septic Shock Treatment Players by Revenue (2019-2024)
3.1.2 Global Sepsis and Septic Shock Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Sepsis and Septic Shock Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis and Septic Shock Treatment Revenue
3.4 Global Sepsis and Septic Shock Treatment Market Concentration Ratio
3.4.1 Global Sepsis and Septic Shock Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis and Septic Shock Treatment Revenue in 2023
3.5 Sepsis and Septic Shock Treatment Key Players Head office and Area Served
3.6 Key Players Sepsis and Septic Shock Treatment Product Solution and Service
3.7 Date of Enter into Sepsis and Septic Shock Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis and Septic Shock Treatment Breakdown Data by Type
4.1 Global Sepsis and Septic Shock Treatment Historic Market Size by Type (2019-2024)
4.2 Global Sepsis and Septic Shock Treatment Forecasted Market Size by Type (2025-2030)
5 Sepsis and Septic Shock Treatment Breakdown Data by Application
5.1 Global Sepsis and Septic Shock Treatment Historic Market Size by Application (2019-2024)
5.2 Global Sepsis and Septic Shock Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sepsis and Septic Shock Treatment Market Size (2019-2030)
6.2 North America Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sepsis and Septic Shock Treatment Market Size by Country (2019-2024)
6.4 North America Sepsis and Septic Shock Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sepsis and Septic Shock Treatment Market Size (2019-2030)
7.2 Europe Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sepsis and Septic Shock Treatment Market Size by Country (2019-2024)
7.4 Europe Sepsis and Septic Shock Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis and Septic Shock Treatment Market Size (2019-2030)
8.2 Asia-Pacific Sepsis and Septic Shock Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sepsis and Septic Shock Treatment Market Size (2019-2030)
9.2 Latin America Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sepsis and Septic Shock Treatment Market Size by Country (2019-2024)
9.4 Latin America Sepsis and Septic Shock Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis and Septic Shock Treatment Market Size (2019-2030)
10.2 Middle East & Africa Sepsis and Septic Shock Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sepsis and Septic Shock Treatment Introduction
11.1.4 Pfizer Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 NCPC
11.2.1 NCPC Company Detail
11.2.2 NCPC Business Overview
11.2.3 NCPC Sepsis and Septic Shock Treatment Introduction
11.2.4 NCPC Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.2.5 NCPC Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Sepsis and Septic Shock Treatment Introduction
11.3.4 Bayer Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Shanghai Pharmaceuticals
11.4.1 Shanghai Pharmaceuticals Company Detail
11.4.2 Shanghai Pharmaceuticals Business Overview
11.4.3 Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Introduction
11.4.4 Shanghai Pharmaceuticals Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.4.5 Shanghai Pharmaceuticals Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Sepsis and Septic Shock Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Sepsis and Septic Shock Treatment Introduction
11.6.4 Novartis Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Sepsis and Septic Shock Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 TEVA
11.8.1 TEVA Company Detail
11.8.2 TEVA Business Overview
11.8.3 TEVA Sepsis and Septic Shock Treatment Introduction
11.8.4 TEVA Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.8.5 TEVA Recent Development
11.9 Viatris
11.9.1 Viatris Company Detail
11.9.2 Viatris Business Overview
11.9.3 Viatris Sepsis and Septic Shock Treatment Introduction
11.9.4 Viatris Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.9.5 Viatris Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Sepsis and Septic Shock Treatment Introduction
11.10.4 AbbVie Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.10.5 AbbVie Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Detail
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Sepsis and Septic Shock Treatment Introduction
11.11.4 Merck & Co Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.11.5 Merck & Co Recent Development
11.12 Asahi Kasei
11.12.1 Asahi Kasei Company Detail
11.12.2 Asahi Kasei Business Overview
11.12.3 Asahi Kasei Sepsis and Septic Shock Treatment Introduction
11.12.4 Asahi Kasei Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.12.5 Asahi Kasei Recent Development
11.13 AtoxBio
11.13.1 AtoxBio Company Detail
11.13.2 AtoxBio Business Overview
11.13.3 AtoxBio Sepsis and Septic Shock Treatment Introduction
11.13.4 AtoxBio Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.13.5 AtoxBio Recent Development
11.14 INOTREM
11.14.1 INOTREM Company Detail
11.14.2 INOTREM Business Overview
11.14.3 INOTREM Sepsis and Septic Shock Treatment Introduction
11.14.4 INOTREM Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.14.5 INOTREM Recent Development
11.15 Adrenomed
11.15.1 Adrenomed Company Detail
11.15.2 Adrenomed Business Overview
11.15.3 Adrenomed Sepsis and Septic Shock Treatment Introduction
11.15.4 Adrenomed Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.15.5 Adrenomed Recent Development
11.16 Endacea
11.16.1 Endacea Company Detail
11.16.2 Endacea Business Overview
11.16.3 Endacea Sepsis and Septic Shock Treatment Introduction
11.16.4 Endacea Revenue in Sepsis and Septic Shock Treatment Business (2019-2024)
11.16.5 Endacea Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sepsis and Septic Shock Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Cephalosporin
    Table 3. Key Players of Pencillin
    Table 4. Key Players of Macrolides
    Table 5. Key Players of Others
    Table 6. Global Sepsis and Septic Shock Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Sepsis and Septic Shock Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Sepsis and Septic Shock Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Sepsis and Septic Shock Treatment Market Share by Region (2019-2024)
    Table 10. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Sepsis and Septic Shock Treatment Market Share by Region (2025-2030)
    Table 12. Sepsis and Septic Shock Treatment Market Trends
    Table 13. Sepsis and Septic Shock Treatment Market Drivers
    Table 14. Sepsis and Septic Shock Treatment Market Challenges
    Table 15. Sepsis and Septic Shock Treatment Market Restraints
    Table 16. Global Sepsis and Septic Shock Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Sepsis and Septic Shock Treatment Market Share by Players (2019-2024)
    Table 18. Global Top Sepsis and Septic Shock Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis and Septic Shock Treatment as of 2023)
    Table 19. Ranking of Global Top Sepsis and Septic Shock Treatment Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Sepsis and Septic Shock Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Sepsis and Septic Shock Treatment Product Solution and Service
    Table 23. Date of Enter into Sepsis and Septic Shock Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Sepsis and Septic Shock Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Sepsis and Septic Shock Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Sepsis and Septic Shock Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2019-2024)
    Table 31. Global Sepsis and Septic Shock Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Sepsis and Septic Shock Treatment Revenue Market Share by Application (2025-2030)
    Table 33. North America Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Sepsis and Septic Shock Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Sepsis and Septic Shock Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Sepsis and Septic Shock Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Sepsis and Septic Shock Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Sepsis and Septic Shock Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Sepsis and Septic Shock Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Sepsis and Septic Shock Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Sepsis and Septic Shock Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Sepsis and Septic Shock Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Sepsis and Septic Shock Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Pfizer Company Detail
    Table 49. Pfizer Business Overview
    Table 50. Pfizer Sepsis and Septic Shock Treatment Product
    Table 51. Pfizer Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 52. Pfizer Recent Development
    Table 53. NCPC Company Detail
    Table 54. NCPC Business Overview
    Table 55. NCPC Sepsis and Septic Shock Treatment Product
    Table 56. NCPC Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 57. NCPC Recent Development
    Table 58. Bayer Company Detail
    Table 59. Bayer Business Overview
    Table 60. Bayer Sepsis and Septic Shock Treatment Product
    Table 61. Bayer Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 62. Bayer Recent Development
    Table 63. Shanghai Pharmaceuticals Company Detail
    Table 64. Shanghai Pharmaceuticals Business Overview
    Table 65. Shanghai Pharmaceuticals Sepsis and Septic Shock Treatment Product
    Table 66. Shanghai Pharmaceuticals Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 67. Shanghai Pharmaceuticals Recent Development
    Table 68. Johnson & Johnson Company Detail
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Sepsis and Septic Shock Treatment Product
    Table 71. Johnson & Johnson Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 72. Johnson & Johnson Recent Development
    Table 73. Novartis Company Detail
    Table 74. Novartis Business Overview
    Table 75. Novartis Sepsis and Septic Shock Treatment Product
    Table 76. Novartis Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 77. Novartis Recent Development
    Table 78. GlaxoSmithKline Company Detail
    Table 79. GlaxoSmithKline Business Overview
    Table 80. GlaxoSmithKline Sepsis and Septic Shock Treatment Product
    Table 81. GlaxoSmithKline Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 82. GlaxoSmithKline Recent Development
    Table 83. TEVA Company Detail
    Table 84. TEVA Business Overview
    Table 85. TEVA Sepsis and Septic Shock Treatment Product
    Table 86. TEVA Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 87. TEVA Recent Development
    Table 88. Viatris Company Detail
    Table 89. Viatris Business Overview
    Table 90. Viatris Sepsis and Septic Shock Treatment Product
    Table 91. Viatris Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 92. Viatris Recent Development
    Table 93. AbbVie Company Detail
    Table 94. AbbVie Business Overview
    Table 95. AbbVie Sepsis and Septic Shock Treatment Product
    Table 96. AbbVie Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 97. AbbVie Recent Development
    Table 98. Merck & Co Company Detail
    Table 99. Merck & Co Business Overview
    Table 100. Merck & Co Sepsis and Septic Shock Treatment Product
    Table 101. Merck & Co Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 102. Merck & Co Recent Development
    Table 103. Asahi Kasei Company Detail
    Table 104. Asahi Kasei Business Overview
    Table 105. Asahi Kasei Sepsis and Septic Shock Treatment Product
    Table 106. Asahi Kasei Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 107. Asahi Kasei Recent Development
    Table 108. AtoxBio Company Detail
    Table 109. AtoxBio Business Overview
    Table 110. AtoxBio Sepsis and Septic Shock Treatment Product
    Table 111. AtoxBio Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 112. AtoxBio Recent Development
    Table 113. INOTREM Company Detail
    Table 114. INOTREM Business Overview
    Table 115. INOTREM Sepsis and Septic Shock Treatment Product
    Table 116. INOTREM Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 117. INOTREM Recent Development
    Table 118. Adrenomed Company Detail
    Table 119. Adrenomed Business Overview
    Table 120. Adrenomed Sepsis and Septic Shock Treatment Product
    Table 121. Adrenomed Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 122. Adrenomed Recent Development
    Table 123. Endacea Company Detail
    Table 124. Endacea Business Overview
    Table 125. Endacea Sepsis and Septic Shock Treatment Product
    Table 126. Endacea Revenue in Sepsis and Septic Shock Treatment Business (2019-2024) & (US$ Million)
    Table 127. Endacea Recent Development
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sepsis and Septic Shock Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Sepsis and Septic Shock Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Cephalosporin Features
    Figure 4. Pencillin Features
    Figure 5. Macrolides Features
    Figure 6. Others Features
    Figure 7. Global Sepsis and Septic Shock Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Sepsis and Septic Shock Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Sepsis Case Studies
    Figure 10. Septic Shock Case Studies
    Figure 11. Sepsis and Septic Shock Treatment Report Years Considered
    Figure 12. Global Sepsis and Septic Shock Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Sepsis and Septic Shock Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Sepsis and Septic Shock Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Sepsis and Septic Shock Treatment Market Share by Players in 2023
    Figure 16. Global Top Sepsis and Septic Shock Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis and Septic Shock Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Sepsis and Septic Shock Treatment Revenue in 2023
    Figure 18. North America Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Sepsis and Septic Shock Treatment Market Share by Country (2019-2030)
    Figure 20. United States Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Sepsis and Septic Shock Treatment Market Share by Country (2019-2030)
    Figure 24. Germany Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Sepsis and Septic Shock Treatment Market Share by Region (2019-2030)
    Figure 32. China Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Sepsis and Septic Shock Treatment Market Share by Country (2019-2030)
    Figure 40. Mexico Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Sepsis and Septic Shock Treatment Market Share by Country (2019-2030)
    Figure 44. Turkey Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Sepsis and Septic Shock Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Pfizer Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 47. NCPC Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 48. Bayer Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 49. Shanghai Pharmaceuticals Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 51. Novartis Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 52. GlaxoSmithKline Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 53. TEVA Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 54. Viatris Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 55. AbbVie Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 56. Merck & Co Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 57. Asahi Kasei Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 58. AtoxBio Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 59. INOTREM Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 60. Adrenomed Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 61. Endacea Revenue Growth Rate in Sepsis and Septic Shock Treatment Business (2019-2024)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Dual Chamber Temporary Pacemaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Y14435
Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Self-adhesive Pain Relief Patches - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-19Y14090
Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Stereotactic Radiosurgery (SRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-14C14333
Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Vascular Surgery Magnifier - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-23I17442
Fri Nov 08 00:00:00 UTC 2024

Add to Cart